December Orange: skin cancer accounts for 33% of malignant tumors in Brazil NEWS

28/12/2018

December Orange: skin cancer accounts for 33% of malignant tumors in Brazil

December Orange: skin cancer accounts for 33% of malignant tumors in Brazil

Data from the National Cancer Institute (INCA) indicate that, annually, about 180 thousand new cases of skin cancer appear in Brazil, equivalent to 33% of malignant tumors in the country.

The month of December marks the beginning of summer and also the “December Orange” campaign, a month of combat and awareness about skin cancer. The initiative is from the Brazilian Society of Dermatology (SDB), which, this year, held the 5th national assistance effort, starting on December 1.

According to the SDB, public awareness is one way of reducing the number of cases. “From December this year to March 2019, that is, throughout the summer, actions and information activities will be promoted on the internet, streets, beaches and parks,” it explains.

In addition, SDB recommends the adoption of basic measures, such as: avoiding the times of greater solar incidence (from 10h to 16h); wear wide-brimmed hats, sunglasses with UV protection and clothes that cover a large part of the body; look for shady places as well as maintain good body hydration.

“The medical society also advises on the daily use of sunscreen with a protection factor of at least 30, which must be reapplied at intervals of two to three hours or after long periods of immersion in water,” it says.

#DecemberOrange at HRCPP

The Hospital Regional do Câncer de Presidente Prudente (HRCPP) held an awareness campaign on the use of sunscreen as a preventive agent for skin cancer during the month of December. During four Fridays, esthetician Amanda Vilas Boas visited the hospital to advise patients and companions on the use of sunscreen and the correct application.

What you should know about skin cancer?

To know more about skin cancer, watch the video below, with guidance and clarification from HRCPP’s technical director and oncologist, Luiz Antônio Bugalho.